These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 16850244

  • 1. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
    Carreño G, Del Casar JM, Corte MD, González LO, Bongera M, Merino AM, Juan G, Obregón R, Martínez E, Vizoso FJ.
    Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 3. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Apr 12; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

  • 4. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
    Haffty BG, Hauser A, Choi DH, Parisot N, Rimm D, King B, Carter D.
    Cancer; 2004 Jan 15; 100(2):252-63. PubMed ID: 14716758
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, Danish Breast Cancer Cooperative Group.
    J Clin Oncol; 2008 Mar 20; 26(9):1419-26. PubMed ID: 18285604
    [Abstract] [Full Text] [Related]

  • 6. Recurrence in breast cancer. Analysis with frailty model.
    Gohari MR, Mahmoudi M, Mohammed K, Pasha E, Khodabakhshi R.
    Saudi Med J; 2006 Aug 20; 27(8):1187-93. PubMed ID: 16883450
    [Abstract] [Full Text] [Related]

  • 7. Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
    Amornmarn R, Bui MM, Prempree TB, Masood S.
    Ann Clin Lab Sci; 2000 Jan 20; 30(1):33-40. PubMed ID: 10678581
    [Abstract] [Full Text] [Related]

  • 8. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J, Kiricuta IC, Kölbl O.
    Strahlenther Onkol; 1995 Jan 20; 171(1):18-28. PubMed ID: 7839301
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
    Lê MG, Arriagada R, Spielmann M, Guinebretière JM, Rochard F.
    Cancer; 2002 Jun 01; 94(11):2813-20. PubMed ID: 12115367
    [Abstract] [Full Text] [Related]

  • 10. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.
    Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J.
    Clin Cancer Res; 2003 Mar 01; 9(3):923-30. PubMed ID: 12631589
    [Abstract] [Full Text] [Related]

  • 11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.
    Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228
    [Abstract] [Full Text] [Related]

  • 12. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
    Kyndi M, Overgaard M, Nielsen HM, Sørensen FB, Knudsen H, Overgaard J.
    Radiother Oncol; 2009 Jan 01; 90(1):74-9. PubMed ID: 18471914
    [Abstract] [Full Text] [Related]

  • 13. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM.
    Cancer; 2003 Feb 01; 97(3):545-53. PubMed ID: 12548595
    [Abstract] [Full Text] [Related]

  • 14. Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome.
    Courdi A, Largillier R, Ferrero JM, Lallement M, Raoust I, Ettore F, Peyrottes I, Chamorey E, Balu-Maestro C, Chapellier C.
    Oncology; 2006 Feb 01; 71(5-6):361-8. PubMed ID: 17785993
    [Abstract] [Full Text] [Related]

  • 15. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?
    Vicini FA, Kestin L, Huang R, Martinez A.
    Cancer; 2003 Feb 15; 97(4):910-9. PubMed ID: 12569590
    [Abstract] [Full Text] [Related]

  • 16. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
    Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR.
    J Clin Oncol; 2008 May 10; 26(14):2373-8. PubMed ID: 18413639
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J.
    Magy Onkol; 2007 May 10; 51(2):127-31. PubMed ID: 17660868
    [Abstract] [Full Text] [Related]

  • 19. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG.
    Cancer; 2000 Mar 01; 88(5):1091-8. PubMed ID: 10699900
    [Abstract] [Full Text] [Related]

  • 20. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.
    Croat Med J; 2006 Feb 01; 47(1):32-41. PubMed ID: 16489695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.